Genome-wide functional integration identified MAZ-controlled RPS14 dysregulation in hepatocellular carcinoma

Linyu Han,Yanfei Huo,Linying Huang,Yanxiu Zheng,Xinyuan Yu,Nasha Zhang,Ming Yang

DOI: https://doi.org/10.1007/s00204-023-03669-z

2024-01-09

Archives of Toxicology

Abstract:Chronic infection with Hepatitis B virus (HBV) significantly increases the risk of hepatocellular carcinoma (HCC), particularly in Eastern Asia. However, only a subset of individuals with chronic HBV infection develop HCC, suggesting the role for genetic factors in HCC etiology. Despite genome-wide association studies (GWASs) identifying multiple single nucleotide polymorphisms (SNPs) associated with HBV-related HCC susceptibility, the underlying mechanisms and causal genetic polymorphisms remain largely unclear. To address this, we developed T he U pdated I ntegrative F unctional G enomics A pproach (TUIFGA), an methodology that combines data from transcription factor (TF) cistromics, ATAC-seq, DNAase-seq, and the 1000 Genomes Project to identify cancer susceptibility SNPs within TF-binding sites across human genome. Using TUIFGA, we discovered SNP rs13170300 which located in the TF MAZ binding motif of RPS14 . The RPS14 rs13170300 was significantly associated with HCC risk in two case–control sets, with the T allele as the protective allele (Shandong discovery set: TT OR = 0.60, 95% CI = 0.49–0.74, P = 1.0 × 10 –6 ; CT OR = 0.69, 95% CI = 0.55–0.86, P = 0.001; Jiangsu validation set: TT OR = 0.70, 95% CI = 0.56–0.87, P = 0.001; CT OR = 0.65, 95% CI = 0.53–0.82, P = 1.6 × 10 –4 ). SNP rs13170300 affected MAZ binding in the RPS14 promoter, resulting in allele-specific changes in gene expression. RPS14 functions as a novel oncogene in HCC, specifically via activating the AKT signaling. Our findings present important insights into the functional genetics underlying HBV-related HCC development and may contribute to personalized approaches for cancer prevention and novel therapeutics.

toxicology